Tumour response rate (taxane‐containing doublet therapy vs taxane monotherapy) · advanced gastric adenocarcinoma
It is very uncertain whether chemotherapy changes tumour response rate (taxane‐containing doublet therapy vs taxane… compared with chemotherapy (very low certainty).
1 finding from 1 review
Adverse events · advanced gastric adenocarcinoma
1 finding from 1 review
Quality of life · advanced gastric adenocarcinoma
1 finding from 1 review
Tumour response · advanced gastric and oesophago‐gastric junction adenocarcinoma
Chemotherapy showed no clear difference in tumour response rate compared with placebo, best supportive care (BSC) or no treatment (low certainty).
1 finding from 1 review
Any adverse events · advanced gastric and oesophago‐gastric junction adenocarcinoma
Chemotherapy showed no clear difference in any adverse events compared with placebo, best supportive care (BSC) or no treatment (high certainty).
1 finding from 1 review
Overall survival · advanced gastric and oesophago‐gastric junction adenocarcinoma
Biological therapy leads to lower overall survival compared with placebo, best supportive care (BSC) or no treatment (high certainty).
1 finding from 1 review
Progression‐free survival · advanced gastric and oesophago‐gastric junction adenocarcinoma
Biological therapy probably leads to lower progression‐free survival compared with placebo, best supportive care (BSC) or no treatment (moderate certainty).
1 finding from 1 review
Serious adverse events · advanced gastric and oesophago‐gastric junction adenocarcinoma
Biological therapy showed no clear difference in serious adverse events compared with placebo, best supportive care (BSC) or no treatment (low certainty).
1 finding from 1 review
Tumour response · advanced gastric and oesophago‐gastric junction adenocarcinoma
Biological therapy may leads to higher tumour response rate compared with placebo, best supportive care (BSC) or no treatment (low certainty).
1 finding from 1 review
Surgical site infection · skin closure in non‐obstetric surgery
Subcuticular sutures showed no clear difference in surgical site infection (SSI) Incidence of wound infection compared with transdermal sutures (low certainty).
1 finding from 1 review
Wound dehiscence · skin closure in non‐obstetric surgery
Subcuticular sutures may leads to lower wound dehiscence Incidence of wound dehiscence compared with skin staples (low certainty).
1 finding from 1 review
Cosmesis of scar · skin closure in non‐obstetric surgery
Subcuticular sutures showed no clear difference in cosmesis of scar compared with skin staples (low certainty).
1 finding from 1 review
Patient satisfaction (at 30 days) · skin closure in non‐obstetric surgery
Subcuticular sutures leads to higher patient satisfaction (at 30 days) compared with skin staples (high certainty).
1 finding from 1 review
Wound closure time (minutes) · skin closure in non‐obstetric surgery
1 finding from 1 review
Costs · skin closure in non‐obstetric surgery
1 finding from 1 review
Surgical site infection · skin closure in non‐obstetric surgery
Subcuticular sutures showed no clear difference in surgical site infection Incidence of wound infection compared with tissue adhesives (moderate certainty).
1 finding from 1 review
Wound complications · skin closure in non‐obstetric surgery
Subcuticular sutures showed no clear difference in wound complications Incidence of wound complications compared with tissue adhesives (low certainty).
1 finding from 1 review
Wound dehiscence · skin closure in non‐obstetric surgery
Subcuticular sutures may leads to lower wound dehiscence Incidence of wound dehiscence compared with tissue adhesives (low certainty).
1 finding from 1 review
Cosmesis of scar · skin closure in non‐obstetric surgery
1 finding from 1 review
Patient satisfaction (within 30 days) · skin closure in non‐obstetric surgery
Subcuticular sutures showed no clear difference in patient satisfaction (within 30 days) compared with tissue adhesives (low certainty).
1 finding from 1 review